Dermatology, MOHS-Micrographic Surgery · Tampa, FL
NPI
1316203110
Since 2012
Specialty
Dermatology, MOHS-Micrographic Surgery
Code 207ND0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
12902 Usf Magnolia Dr
Tampa, FL, 33612
Phone (813) 745-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
2,238 services
Medicare patients, 2024
439
Average age 74
Drug cost, 2024
$504K
873 prescriptions
Company payments, 2025
$3,125
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lilia M Correa was code 17003 (destruction skin lesion), 402 times for 89 patients. In total Lilia M Correa billed 2,238 services in 84 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 402 | 89 | $4.93 | $1,983 |
| 99214 Office E&M - Established | Office | 235 | 149 | $92.13 | $22K |
| 17000 Destruction Skin Lesion | Office | 178 | 128 | $38.41 | $6,838 |
| 99213 Office E&M - Established | Office | 157 | 120 | $63.89 | $10K |
| 99214 Office E&M - Established | Facility | 89 | 63 | $68.62 | $6,107 |
| 17110 Destruction Skin Lesion | Office | 81 | 67 | $81.54 | $6,605 |
| 17311 Mohs Surgery | Office | 81 | 59 | $434.28 | $35K |
| 17312 Mohs Surgery | Office | 76 | 36 | $309.67 | $24K |
| 11102 Skin Biopsy | Office | 75 | 59 | $62.27 | $4,670 |
| 17000 Destruction Skin Lesion | Facility | 71 | 55 | $36.74 | $2,608 |
| 99213 Office E&M - Established | Facility | 54 | 41 | $48.52 | $2,620 |
| 17003 Destruction Skin Lesion | Facility | 53 | 45 | $1.51 | $79.81 |
| 12032 Wound Repair - All Levels | Office | 51 | 45 | $167.07 | $8,521 |
| 11102 Skin Biopsy | Facility | 43 | 34 | $20.50 | $882 |
| 11602 Skin Lesion Excision | Office | 34 | 28 | $96.48 | $3,280 |
By year: 2022 $109K for 1,600 services; 2023 $195K for 1,863 services; 2024 $206K for 2,238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lilia M Correa prescribed most often to Medicare patients was Mupirocin, with 95 prescriptions and refills. In total Lilia M Correa wrote 873 Medicare prescriptions that cost $504K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 95 | 96 | 70 | $717 |
| Ketoconazole Generic | 86 | 89 | 42 | $982 |
| Triamcinolone Acetonide Generic | 53 | 58 | 41 | $606 |
| Clobetasol Propionate Generic | 38 | 41 | 22 | $1,162 |
| Fluorouracil Generic | 28 | 32 | 24 | $1,900 |
| Nystatin Generic | 25 | 27 | 14 | $432 |
| Doxycycline Hyclate Generic | 24 | 32 | Under 11 | $417 |
| Prednisone Generic | 24 | 35 | Under 11 | $355 |
| Mycophenolate Mofetil Generic | 23 | 30 | Under 11 | $1,562 |
| Spironolactone Generic | 21 | 27 | Under 11 | $139 |
| Clotrimazole Generic | 20 | 20 | Under 11 | $525 |
| Cephalexin Generic | 19 | 19 | 15 | $145 |
| Acitretin Generic | 19 | 20 | Under 11 | $9,526 |
| Valacyclovir Valacyclovir Hcl | 18 | 18 | Under 11 | $407 |
| Imiquimod Generic | 16 | 20 | Under 11 | $522 |
Brand drugs: 105 claims; generic drugs: 768 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lilia M Correa $3,125 ($1,731 in general payments such as food, travel and fees and $1,394 for research) from 12 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $1,394.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 10 | $1,394 |
| Galderma Laboratories, L.P. GALD.SW | 4 | $369 |
| Genzyme Corporation SNY | 1 | $192 |
| MIMEDX Group, Inc. MDXG | 2 | $173 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $171 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $169 |
| ConvaTec Inc. CTEC.L | 2 | $132 |
| Pfizer Inc. PFE | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $120 |
| Abbvie Inc. ABBV | 1 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.